Compounds > substance p
Page last updated: 2024-08-23

substance p and beta-funaltrexamine

substance p has been researched along with beta-funaltrexamine in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19902 (33.33)18.7374
1990's3 (50.00)18.2507
2000's1 (16.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Larson, AA; Mousseau, DD; Sun, X1
Cherubini, E; North, RA; Tokimasa, T1
Hylden, JL; Wilcox, GL1
Kameyama, T; Shinkai, N; Ukai, M1
Arcaya, JL; Cano, G; Gómez, G; Maixner, W; Suárez-Roca, H1
Honda, T; Nagase, H; Nakao, K; Okano, K; Tanaka, T; Togashi, Y; Umeuchi, H1

Other Studies

6 other study(ies) available for substance p and beta-funaltrexamine

ArticleYear
Identification of a novel receptor mediating substance P-induced behavior in the mouse.
    European journal of pharmacology, 1992, Jul-07, Volume: 217, Issue:2-3

    Topics: Analysis of Variance; Animals; Behavior, Animal; Binding Sites; Indoles; Injections, Spinal; Male; Mice; Morphinans; Naloxone; Naltrexone; Peptide Fragments; Substance P

1992
Action of naloxone on myenteric neurons removed from morphine-treated guinea pigs.
    The Journal of pharmacology and experimental therapeutics, 1988, Volume: 247, Issue:3

    Topics: Acetylcholine; Action Potentials; Animals; Endorphins; Guinea Pigs; Ileum; In Vitro Techniques; Magnesium; Morphine; Muscle Contraction; Myenteric Plexus; Naloxone; Naltrexone; Substance P

1988
Pharmacological characterization of substance P-induced nociception in mice: modulation by opioid and noradrenergic agonists at the spinal level.
    The Journal of pharmacology and experimental therapeutics, 1983, Volume: 226, Issue:2

    Topics: Animals; Dose-Response Relationship, Drug; Endorphins; Male; Mice; Naltrexone; Nociceptors; Norepinephrine; Receptors, Adrenergic, alpha; Spinal Cord; Substance P

1983
Ameliorative effects of tachykinins on scopolamine-induced impairment of spontaneous alternation performance in mice.
    Methods and findings in experimental and clinical pharmacology, 1998, Volume: 20, Issue:7

    Topics: Animals; Male; Mice; Muscarinic Antagonists; Naloxone; Naltrexone; Narcotic Antagonists; Neurokinin A; Peptide Fragments; Psychomotor Performance; Scopolamine; Substance P; Tachykinins

1998
Dynorphin A increases substance P release from trigeminal primary afferent C-fibers.
    European journal of pharmacology, 1999, Jan-29, Volume: 366, Issue:1

    Topics: Animals; Animals, Newborn; Capsaicin; Dizocilpine Maleate; Dynorphins; Enkephalin, Leucine; Excitatory Amino Acid Antagonists; In Vitro Techniques; Male; Naloxone; Naltrexone; Narcotic Antagonists; Nerve Fibers; Neurons, Afferent; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Substance P; Trigeminal Nuclei

1999
Involvement of central mu-opioid system in the scratching behavior in mice, and the suppression of it by the activation of kappa-opioid system.
    European journal of pharmacology, 2003, Sep-05, Volume: 477, Issue:1

    Topics: Animals; Antipruritics; Behavior, Animal; Injections, Intraventricular; Injections, Subcutaneous; Ketotifen; Male; Mice; Morphinans; Morphine; Motor Activity; Naltrexone; Narcotic Antagonists; Pruritus; Receptors, Opioid, kappa; Receptors, Opioid, mu; Spiro Compounds; Substance P

2003